Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay

Clinical and Vaccine Immunology

Volumn 13, Issue 2, 2006, Pages 214-218

  Maple, P A C ^a   Gray, J ^a   Breuer, J ^b   Kafatos, G ^a   Parker, S ^b   Brown, D ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ARTICLE; ENZYME IMMUNOASSAY; GLYCOPROTEIN ENZYME IMMUNOASSAY; HUMAN; IMMUNE STATUS; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERUM; TIME RESOLVED FLUORESCENCE IMMUNOASSAY; VACCINATION; VALIDITY; VARICELLA ZOSTER VIRUS;

ADULT; ANTIBODIES, VIRAL; FLUOROIMMUNOASSAY; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; SENSITIVITY AND SPECIFICITY;

EID: 33644917997     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.2.214-218.2006     Document Type: Article

References (24)

1. Anonymous. 1996. Varicella, p. 251-261. In D. M. Salisbury and N. T. Begg (ed.), Immunisation against infectious disease. HMSO, London, United Kingdom.
2. Balfour, H. H., C. K. Edelman, C. L. Dirksen, D. R. Palermo, C. S. Suarez, J. Kelly, J. T. Kentala, and D. D. Crane. 1988. Laboratory studies of acute varicella and varicella immune status. Diagn. Microbiol. Infect. Dis. 10:149-158.
3. Bogger-Goren, S., K. Baba, P. Hurley, H. Yabuuchi, M. Takahashi, and P. L. Ogra. 1982. Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J. Infect. Dis. 146:260-265.
4. Breuer, J. 2001. Vaccination to prevent varicella and shingles. J. Clin. Pathol. 54:743-747.
5. Brisson, M., W. J. Edmunds, N. J. Gay, B. Law, and G. De Serres. 2000. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol. Infect. 125:651-669.
6. Demmler, G. J., S. P. Steinberg, G. Blum, and A. A. Gershon. 1988. Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus. J. Infect. Dis. 157:211-212.
7. Diaz, P. S., S. Smith, E. Hunter, and A. M. Arvin. 1988. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine. J. Infect. Dis. 158:1245-1252.
8. Edmunds, W. J., M. Brisson, N. J. Gay, and E. Miller. 2002. Varicella vaccination: a double edged sword? Commun. Dis. Public Health 5:185-186.
9. Gay, N. J. 1996. Analysis of serological surveys using mixture models: application to a survey of parvovirus B19. Stat. Med. 15:1567-1573.
10. Krah, D. L., P. J. Provost, and R. W. Ellis. 1995. Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus. J. Virol. Methods 53:176-187.
11. Krah, D. L. 1996. Assays for antibodies to varicella-zoster virus. Infect. Dis. Clin. N. Am. 10:507-526.
12. Larussa, P., S. Steinberg, E. Waithe, B. Hanna, and R. Holzman. 1987. Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test. J. Clin. Microbiol. 25:2059-2062.
13. Lerman, Y., G. Chodick, S. Tepper, G. Livni, and S. Ashkenazi. 2004. Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers. Epidemiol. Infect. 132:1135-1138.
14. Maple, P. A. C., and C. S. Jones. 2002. Time-resolved fluorometric immunoassay for rubella antibody-a useful method for serosurveillance studies. Vaccine 20:1378-1382.
15. McKie, A., A. Vyse, and C. Maple. 2002. Novel methods for the detection of microbial antibodies in oral fluid. Lancet Infect. Dis. 2:18-24.
16. Miller, E., R. Marshall, and J. Vurdien. 1993. Epidemiology, outcome and control of varicella-zoster infection. Rev. Med. Microbiol. 4:222-230.
17. Preblud, S. R. 1981. Age-specific risks of varicella complications. Pediatrics 68:14-17.
18. Provost, P. J., D. L. Krah, B. J. Kuter, D. H. Morton, T. L. Schofield, E. H. Wasmuth, J. White, W. J. Miller, and R. W. Ellis. 1991. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 9:111-116.
19. Robertson, P. W., S. M. Bell, and M. J. Ferson. 1989. A method for determining the cut-off value of a varicella-zoster virus IgG enzyme immunoassay for immune status. J. Virol. Methods 26:115-118.
20. Steinberg, S. P., and A. A. Gershon. 1991. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J. Clin. Microbiol. 29:1527-1529.
21. Wasmuth, E. H., and W. J. Miller. 1990. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J. Med. Virol. 32:189-193.
22. Williams, V., A. A. Gershon, and P. A. Brunell. 1974. Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence. J. Infect. Dis. 130:669-672.
23. Von Hunolstein, C., H. Aggerbeck, N. Andrews, G. Berbers, F. Fievet-Groyne, P. A. C. Maple, R. M. Olander, M. Raux, and A. Tischer. 2000. European Sero-Epidemiology Network: standardisation of the results of diphtheria antitoxin assays. Vaccine 18:3287-3296.
24. Vyse, A. J., N. J. Gay, L. M. Hesketh, P. Morgan-Capner, and E. Miller. 2004. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol. Infect. 132:1129-1134.